Objective: The objective of this study was to evaluate the safety, efficacy, and outcomes of the conformable thoracic endograft (Conformable TAG Thoracic Endoprosthesis [CTAG]; W. L. Gore & Associates, Flagstaff, Ariz) for acute complicated and uncomplicated type B aortic dissection (TBAD).
Acute Stanford type B aortic dissection (ATBAD) presenting with complications, such as organ malperfusion and aortic rupture, is a life-threatening condition. In recent years, thoracic endovascular aortic repair (TEVAR) has emerged as an alternative to open surgery for the management of complicated ATBAD. The VIRTUE study showed that aortic remodeling (ie, expansion of true lumen and regression of false lumen) after TEVAR is a continuous process, suggesting that earlier TEVAR allows better remodeling in patients with complicated ATBAD patients. 1 However, the use of TEVAR to treat uncomplicated ATBAD has not been fully characterized. Despite adequate surveillance and treatment, delayed aorta-related complications, such as aneurysmal dilation and rupture, occur in 25% of patients with uncomplicated ATBAD, requiring TEVAR or open surgery. 2 Therefore, it is important to determine whether uncomplicated ATBAD can be managed by TEVAR in the early stage. Furthermore, the 30-day hospital mortality after TEVAR in complicated ATBAD is 5% to 8%. 3, 4 Most deaths within the 30-day hospital stay are predominantly associated with retrograde type A aortic dissection (RTAD), possibly caused by damage to the fragile aortic wall resulting from the strong proximal spring-back force of the stent graft. 5 Similarly, in uncomplicated ATBAD, the aortic wall is also vulnerable to rupture by the stent graft. Such strong spring-back force is a result of poor conformability of the stent graft against the aortic arch, which was not well taken into account in the design of older stent grafts.
The new design of the Conformable TAG Thoracic Endoprosthesis (CTAG; W. L. Gore & Associates, Flagstaff, Ariz) has undergone several modifications to improve its conformability and adaptable radial force with regard to acute aortic disease. So far, limited data are available on the performance of CTAG for ATBAD. The aim of this study was to report our preliminary outcomes of using a CTAG device for complicated and uncomplicated ATBAD in our center.
METHODS
Study design and primary end points. We performed a prospective, single-arm study of patients with complicated or uncomplicated ATBAD in our center between February and October 2016. The study was designed to evaluate the initial performance and short-term clinical outcomes of CTAG and was approved and supervised by the Institutional Review Board of our hospital. The primary end points were early mortality after TEVAR, conversion to open surgery, complications related to the procedure and CTAG device, and assessment of the conformability of the CTAG device.
Eligibility of patients. Patients with complicated or uncomplicated ATBAD were consecutively included in this study. The term complicated was defined as either malperfusion or contained rupture (hemothorax, increasing periaortic and mediastinal hematoma) or both. 6 If patients were diagnosed with complicated dissection, they usually underwent TEVAR within 48 hours. Likewise, if patients were diagnosed with uncomplicated dissection, they would undergo TEVAR within 7 days based on our previous experience. Patients with subacute and chronic aortic dissection were excluded. In addition, pregnant women, patients with tortuous or stenotic iliac or femoral arteries preventing TEVAR, and patients who were allergic to the contrast agent were excluded. The acute aortic dissection is <14 days of onset, and the subacute aortic dissection is between 15 and 90 days, which strictly referred to the 2014 European Society of Cardiology guidelines on the diagnosis and treatment of aortic disease. 4 All patients agreed to the conditions of the procedure and the use of their data by signing a consent form. All type B aortic dissection (TBAD) patients recruited in our study met the inclusion criteria, and no patients received medical treatment alone. Demographic, preoperative, operative, and follow-up data were analyzed from patient records. Computed tomography angiography (CTA) was performed and evaluated immediately after patients were admitted to our center.
Computed tomography imaging and measurements. CTA scans were performed following a standardized protocol involving the whole aorta with venous and arterial imaging phases. Three-dimensional reconstruction and computed tomography image measurement were performed on a workstation by two experienced radiologists and one vascular surgeon. Conformability of the device (height of bird beak [HBB]) was evaluated by measuring the gap between the radiopaque gold ring at the proximal end of the graft and the inner curvature of the aortic arch on sagittal multiplanar reformations of CTA images. 7 If conformability was observed, the length of the longitudinal segment of the unapposed stent graft (length of bird beak [LBB] ) was recorded. The bird-beak angle of the stent grafts was calculated by the following formula: tanq ¼ HBB/LBB, q ¼ tan À1 (HBB/LBB) (Fig 1) . In addition, two experienced radiologists found the transverse section of the minimal true lumen and the maximal false lumen using the multiplanar reconstruction in the Advantage Workstation 4.3 (GE Healthcare, Wauwatosa, Wisc). We defined the degree of aortic remodeling as the absolute change in aortic area at the transverse section of the minimal true lumen and the maximal false lumen.
TEVAR procedure. All TEVAR procedures were performed in a hybrid interventional suite with patients under general anesthesia. A standardized TEVAR protocol was performed with a standby option of spinal fluid drainage. Briefly, true lumen access was approached after an inguinal cutdown or percutaneous puncture preloaded with two ProGlides (Abbott Vascular, Abbott Park, Ill) based on presurgical CTA. Through a 5F pigtail catheter, TBAD was verified by angiography using 320 mg/mL iodine contrast agent (Visipaque 320; GE Healthcare). After labeling the superarch vessels osmium and primary tear position, a 300-cm-long superstiff wire (Lunderquist; Cook Medical, Bloomington, Ind) was advanced into the true lumen to the ascending aorta, followed by the deployment of an appropriate CTAG device in the correct position. No intravascular ultrasound was used in the TEVAR procedure. The device oversizing was 10% for complicated dissections and 20% for uncomplicated dissections according to the diameter of the proximal landing zone measured in orthogonal view. Blood pressure was controlled to approximately 90 mm Hg using an intravenous drug to avoid windsock effect or misplacement when the device was deployed. Revascularization of supra-arch vessels was performed only with endovascular chimney or periscope techniques to secure proximal landing zone length according to Recommendation: This study suggests that endovascular repair using the conformable thoracic endograft is safe in both complicated and uncomplicated type B aortic dissections and results in favorable short-term aortic remodeling.
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preoperative CTA measurements. Chimney or periscope technique would be considered if the landing zone was <20 mm proximal to the primary entry tear. Oversizing for the chimney or periscope technique was 10% of the diameter of the target vessel based on the instructions for use of the Viabahn (W. L. Gore & Associates). If malperfusion of the end organ still existed after TEVAR, an auxiliary stent in the visceral or lower extremity arteries would be placed. Outcomes and statistical analysis. Outcome criteria were defined according to the reporting standards for TEVAR. Data were analyzed using SPSS 20.0 software (IBM Corp, Armonk, NY). Continuous variables are described by the mean and standard deviation or median and range, and categorical variables are described by frequencies and percentages. Univariate logistic regression analysis was used to assess correlations between clinical variables and bird-beak configuration. Variables correlated with bird-beak configuration in the univariate model with a P value < .2 were included in the multivariate model. A P value < .05 was considered statistically significant.
RESULTS
Characteristics of the patients. Characteristics of the patients are provided in Table I . There were no significant differences between complicated and uncomplicated groups. The mean follow-up time was 8.2 6 3.5 months (range, 4-12 months) . No open surgical conversion was performed in the initial operation or during follow-up. In total, there were five acute complicated dissections when the patients were admitted to our emergency department. One (20%) had acute ischemia in the superior mesenteric artery; two (40%) had malperfusion in the left renal artery; and two (40%) suffered from right iliac artery ischemia. No patient was lost during follow-up, and there were no major adverse events.
TEVAR-related complications. All devices were deployed successfully. Procedure-related data are summarized in Table II . In our study, we performed 10 double-chimney repairs of the left carotid artery and left subclavian artery (LSA), one double-chimney repair of the innominate artery and left carotid artery, and a single periscope (LSA) to secure the device in an adequate normal proximal landing zone. All chimney and periscope grafts were Viabahn grafts. No auxiliary stenting was performed in the visceral or lower extremity arteries in our study. We observed seven bird-beak configurations during follow-up (Fig 2) . Five bird-beak configurations were observed at the 3-month follow-up, and an additional two were observed at the 6-month follow-up. Procedural details of these seven patients are provided in Table III . The median HBB was 3.14 mm (range, 2-4 mm), and the median LBB was 12.86 mm (range, 6-28 mm). Five of seven patients with bird-beak configurations underwent chimney or periscope techniques. Multivariate logistic regression showed that chimney or periscope grafts were significantly associated with a birdbeak configuration (P ¼ .039 ; Table IV ). However, neither arch type (P ¼ .343) nor landing zone (P ¼ .544) was associated with a bird-beak configuration.
There was no mortality, no stroke, and no paraplegia in our study. Furthermore, no RTAD or distal stent-induced new entry (SINE) was observed during follow-up. Only two patients (3.8%) experienced minor wound hematomas without any further treatment. Aortic morphology. The minimal true lumen and maximal false lumen areas were defined in CTA images using analysis software. Both the minimal true lumen area (Fig 3; P ¼ .004) and maximal false lumen area (Fig 4; P ¼ .006) in the complicated group were significantly smaller than those in the uncomplicated group before TEVAR. However, there were no group differences in the minimal true lumen or maximal false lumen areas after TEVAR. Analysis of aortic remodeling showed that the true lumen increased significantly in both complicated and uncomplicated ATBAD (P < .001 and P ¼ .047, respectively; Fig 3) , with no differences between 3-month and 6-month follow-ups. Likewise, the false lumen significantly decreased in uncomplicated dissection (P ¼ .032 ; Fig 4) , but no significant change in the false lumen was detected in complicated dissection. In addition, partial false lumen thrombosis was observed in the device sections while the persistent blood flow was still visible distal to the nondevice sections.
DISCUSSION
To our knowledge, this is the first prospective, singlearm study investigating the safety and efficacy of the CTAG device in treating patients with complicated and uncomplicated ATBAD. Compared with previously published CTAG registries, 4, 8, 9 the distinct difference is that we include the acute uncomplicated dissection to investigate clinical outcomes. Another difference is that we rebuilt the LSA using an endovascular stent graft, whereas others directly covered the LSA in some registries. 4, 8 Our results show that the use of a CTAG device is both feasible and safe for both complicated and uncomplicated cases of ATBAD.
All patients in the current series were treated in the acute phase. First, as we mentioned earlier, delayed aorta-related complications occur in 25% of patients with uncomplicated ATBAD under adequate surveillance, requiring further intervention. Second, the unpublished data from our hemodynamic simulation of complicated and uncomplicated dissections showed that TEVAR in the subacute phase could decrease the positive aortic remodeling compared with that in the acute phase. Therefore, we designed this study to observe the clinical outcome of the CTAG for patients with complicated and uncomplicated ATBAD to further explore its application in the acute phase.
The preliminary consensus is that TEVAR is preferred for complicated TBAD rather than for uncomplicated TBAD in the acute phase. The recently published Acute Dissection: Stent Graft or Best Medical Therapy (ADSORB) trial indicates that TEVAR markedly facilitates aortic remodeling compared with medical therapy. 2 The VIRTUE study also showed a more favorable outcome of aortic remodeling when TEVAR is performed in the acute or subacute phases compared with the chronic phase. 1 However, controversy exists about the most suitable therapy for uncomplicated ATBAD. In general, an optimal medical treatment a Two stent grafts were used in three patients with uncomplicated dissection because of a secondary tear in the descending aorta. No secondary tear was seen in the descending aorta of the patients with complicated dissection. Thus, only a single stent graft was used in five patients with complicated dissection to seal the primary tear. Therefore, the very small sample may bias the P value. b Five patients with complicated dissection with malperfusion had a small true lumen. In 40% of the complicated dissections, the small CTAG device (31 mm) had to be used, which was available only in 150 mm. In general, we prefer the longer device to cover the dissection of the aorta. for uncomplicated TBAD is recommended. However, we and other groups have observed the sudden death of some patients with uncomplicated ATBAD who received medical therapy. Furthermore, 15% to 31% of patients with uncomplicated TBAD need delayed intervention, especially in the first year after surgery. 10 Therefore, we performed TEVAR not only for complicated TBAD but also for uncomplicated TBAD to test its feasibility and safety in treating uncomplicated TBAD.
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On the basis of our previous experience, we preferred to treat patients with uncomplicated TBAD in the subacute phase in the past. 12 Our major concern is that the vessel wall of the aortic dissection is swollen and fragile in the acute phase; therefore, stenting could induce RTAD or aortic wall rupture. It is encouraging that no RTAD or rupture was observed in our study even though the extent of device oversizing reached 20% in cases of acute uncomplicated dissection. This indicates that the CTAG device can well accommodate arch configuration and disease of the vessel wall of the dissection, thereby decreasing spring-back force to the vessel wall. There was no significant difference of complications between the two groups. Furthermore, there was no mortality in both groups. Although the ADSORB trial was designed for acute uncomplicated dissection as well, the treatment involved medical management alone. 2 According to our previous experience, the pathophysiologic variation of the complicated dissection and the uncomplicated dissection is different. Therefore, the aortic remodeling after TEVAR in these two groups could also be different, which preferably led us to treat the acute uncomplicated dissection instead of medical treatment. However, the old-generation device did not perform well. Our data indicated that CTAG is appropriate for the acute complicated and uncomplicated dissection. Of note, there were two patients with Marfan syndrome in our study who received close follow-up. With less spring-back force against the vessel wall, a CTAG device may be a better choice for patients with vasculitis or autoimmune diseases. In terms of our TEVAR experience, the vessel wall of the complicated dissection is much more fragile compared with that of the uncomplicated dissection. Furthermore, our previous data have shown that the true lumen in the complicated dissection is significantly smaller than that in the uncomplicated dissection. According to the data of Lumsden and Bismuth, the radial force of the CTAG would be directly proportional to the size of the CTAG in the same vessel lumen. 13 In other words, the radial force of the CTAG would increase in the small lumen compared with that of the same size CTAG in the bigger lumen. Thus, we chose the 10% oversizing in the complicated dissection and 20% in the uncomplicated dissection. Bird-beak configuration was found in 13.5% (7/52) of patients in our study. According to the CTAG registry investigators, an HBB #2 mm indicates that the device conformed to the arch anatomy. 9 Based on this definition, favorable conformability of the device occurred in 86.5% (45/52) of patients in our study compared with 65% (13/20) in the study of Bischoff et al. 7 Neither the study of Bischoff et al 7 nor our study showed that a steep arch type influenced bird-beak configuration. However, Hsu et al 14 showed that a highly curved arch for stent graft apposition increases the risk of bird-beak configuration. A possible reason for this discrepancy among studies is a difference in the stent graft selected. Whereas Hsu et al 14 used the Zenith Pro-Form TX2 (Cook Medical) thoracic endograft, we used the CTAG device, which further implies that the CTAG device can adapt better to a hostile arch compared with other devices. However, zone 2 landing was associated with a bird-beak configuration in the study of Bischoff et al 7 but not in this study, which might be explained by the heterogeneity of pathologic processes and the limited number of cases in their study. Furthermore, bird-beak configuration was first observed 3 months after TEVAR and sequentially increased along with the follow-up, which was also observed by Hsu et al 14 in their study. The dynamic blood flow, interaction between the device and the vessel wall, true lumen expansion, false lumen regression, and remodeling of the arch after TEVAR could be possible factors to explain the consequent bird-beak configuration with follow-up.
Previous studies show that a bird-beak configuration is associated with endoleaks. 15, 16 Despite the occurrence of seven bird-beak configurations in our study, we observed no endoleaks during postoperative hospitalization or follow-up. rate of immediate type IA endoleak when TBAD patients were treated with TEVAR using the single-chimney technique, with all endoleaks diminishing after immediate angioplasty and disappearing by 1-year follow-up. Most previous studies, however, have generally focused on both aortic dissection and aneurysm rather than on aortic dissection alone. Type IA endoleak occurs at a rate of 6.5% to 10% using the single-chimney technique and up to 15% using the double-chimney technique. [18] [19] [20] In our study, we performed 10 double-chimney techniques and one triple-chimney technique, but none led to type I endoleaks. Therefore, our findings suggest that the CTAG device can excellently conform to the steep aortic arch and decrease the risk of type I endoleak when the chimney technique is necessary (Fig 5) . Consistent with the findings of the VIRTUE Registry and the study of Leshnower et al, 1, 21 our data provide evidence of positive aortic remodeling after TEVAR in patients with complicated TBAD. However, five patients in the complicated group experienced malperfusion syndrome, consistent with our finding that the mean minimal true lumen area was significantly smaller in the complicated group than in the uncomplicated group before TEVAR, whereas the mean maximal false lumen area did not change after TEVAR. Patients with threatened aortic rupture often develop larger false lumen areas, which can substantially decrease after the primary tear is well sealed. Therefore, the inclusion of only five patients who experienced malperfusion syndrome rather than threatened aortic rupture could have biased our results. Furthermore, the very early outcome of the false lumen thrombosis was similar to the data of Kamman et al, 22 who pointed out the false lumen thrombosis as a time-dependent parameter instead of a snapshot characteristic. Thus, we will keep a close follow-up of these patients. Besides, our results indicate that positive aortic remodeling can occur after TEVAR in patients with uncomplicated ATBAD. Therefore, the CTAG device may be appropriate for use in patients with both complicated and uncomplicated ATBAD. This study has some limitations with regard to its design. First, it was a single-arm study rather than a randomized controlled trial, which may affect the generalizability of our primary conclusions. Second, the longest follow-up duration was 12 months, and the mean follow-up duration was approximately 8 months, which could limit our conclusions. For instance, although no SINE was observed in our study, the mean delay before the occurrence of distal SINE is about 42 months. 23 Hence, close longterm follow-up is mandatory for patients. In addition, our study included only a small number of patients with complicated aortic dissection in a single center, which could have influenced the clinical outcomes.
CONCLUSIONS
Our preliminary results show no death, no RTAD, no conversion to open heart surgery, and no endoleaks in patients with complicated and uncomplicated ATBAD treated with a CTAG device. Thus, ATBAD can feasibly and safely be managed with a CTAG device. Our findings should be confirmed by randomized controlled trials and studies employing longer term follow-up. 
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